SCAM WATCH
Before you send money to a peptide supplier, run through this list. Every item on it has cost Canadian buyers real money — or worse.
The Canadian peptide market has a quality problem. Unregulated supply chains, no mandatory testing, and a buyer pool that’s often reluctant to ask hard questions because the whole thing already feels legally ambiguous. That combination is exactly what bad suppliers exploit.
Here are the five red flags that consistently show up before someone gets burned.
1. No Third-Party Certificate of Analysis (COA)
A legitimate COA is issued by an independent, accredited lab — not the supplier’s “in-house quality team.” It should show the compound tested, the purity percentage, the testing method (HPLC is standard), the batch number, and the date.
Red flags: COAs with no lab name, COAs that don’t show a batch number, COAs that are months or years old, COAs that only show one compound when the product contains several. If a supplier won’t provide a COA on request, stop there.
The more sophisticated version of this scam: a real-looking COA for a real batch that has nothing to do with the vial you’re buying. Without the batch number cross-referenced, a COA is just a PDF.
2. Prices That Are Significantly Below Market
High-purity peptides are not cheap to manufacture correctly. If a supplier is selling BPC-157 at 40% below what every other comparable supplier charges, ask why. The answer is usually one of: lower purity, under-dosed product, counterfeit compound, or compromised storage.
This doesn’t mean the most expensive supplier is the best. It means a dramatic price outlier — in either direction — warrants scrutiny. Get the COA, check the purity, compare the actual dosage per vial, not just the per-vial price.
3. No Verifiable Business Presence
A legitimate supplier has a business registration, a physical address, and responsive customer service. They’ve been around long enough to have a real review history — not just five-star reviews that all appeared in the same two-week window.
Check: Is the business registered? Can you find an address that exists on Google Maps? Does the customer service email bounce, go unanswered, or route to a generic contact form with no response? How old is the domain? (A peptide supplier that registered their domain 60 days ago and has 200 reviews is worth questioning.)
4. Explicit Health Claims on the Product Page
This one is a double red flag — legal and quality. A supplier making explicit health claims (“cures tendon injuries,” “proven to heal gut lining,” “increase HGH by 300%”) is either ignorant of or indifferent to Canadian drug regulations. Both are problems.
Suppliers who operate carefully — who understand the regulatory environment — use precise, hedged language. Suppliers who plaster therapeutic claims across their product pages either don’t understand what they’re selling, don’t care about the regulatory exposure they’re creating for their customers, or both.
5. No Cold Chain Information for Temperature-Sensitive Compounds
Many peptides degrade quickly at room temperature. BPC-157, TB-500, and most growth hormone peptides require refrigerated storage and careful shipping. If a supplier doesn’t mention storage requirements, doesn’t offer cold pack shipping for temperature-sensitive compounds, or ships in an uninsulated mailer — the product may be compromised before it arrives.
Ask any supplier directly: how do you ship this compound in summer? What is the recommended storage temperature? How long is the product stable once reconstituted? A supplier who can’t answer these questions clearly doesn’t know their product well enough to sell it.
The Pattern Behind the Flags
Every one of these red flags points to the same thing: a supplier who hasn’t invested in doing this properly. That might mean the product is underdosed. It might mean the purity is lower than claimed. It might mean the storage conditions were wrong. In the worst cases, it means the compound is mislabelled entirely.
The risk isn’t just wasted money. It’s putting an unknown substance into your body and calling it something it may not be.
This article reflects our editorial assessment of common supplier risk patterns. We encourage readers to conduct their own due diligence. If you’ve encountered a supplier you believe is operating fraudulently, contact Health Canada’s MedEffect program.